Sanofi AI Drug Discovery Deal Bolsters Baidu-Backed Startup BioMap
But Field Faces Data, Other Challenges
As artificial intelligence-aided drug discovery gains momentum, Sanofi appears keen to hop onboard via a recent tie-up with leading Chinese AI company BioMap. But data challenges, a hard-to-define value proposition, concerns over data security and looming regulations are making others hesitant.
